0001209191-23-037122.txt : 20230614 0001209191-23-037122.hdr.sgml : 20230614 20230614173540 ACCESSION NUMBER: 0001209191-23-037122 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREY MICHAEL G CENTRAL INDEX KEY: 0001240122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 231015228 MAIL ADDRESS: STREET 1: C/O SGX PHARMACEUTICALS, INC. STREET 2: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001240122 GREY MICHAEL G C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 1 0 0 0 0 Stock Option (right to buy) 28.97 2023-06-12 4 A 0 17000 0.00 A 2033-06-11 Common Stock 17000 17000 D The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting. /s/ Judit Ryvkin, Attorney-in-Fact 2023-06-14